Ken Griffin Absci Corp Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$2.97 - $4.49 $86,724 - $131,108	-29,200 Reduced 34.89%	54,500 $208,000
Q2 2024 Aug 14, 2024	SELL	$2.92 - $6.58 $20,148 - $45,402	-6,900 Reduced 7.62%	83,700 $257,000
Q1 2024 May 15, 2024	BUY	$3.41 - $5.74 $283,712 - $477,568	83,200 Added 1124.32%	90,600 $514,000
Q4 2023 Feb 14, 2024	SELL	$1.15 - $4.79 $8,049 - $33,530	-7,000 Reduced 48.61%	7,400 $31,000
Q3 2023 Nov 14, 2023	SELL	$1.28 - $2.41 $19,072 - $35,909	-14,900 Reduced 50.85%	14,400 $19,000
Q2 2023 Aug 14, 2023	SELL	$1.17 - $2.03 $24,687 - $42,832	-21,100 Reduced 41.87%	29,300 $44,000
Q1 2023 May 15, 2023	BUY	$1.58 - $3.41 $41,080 - $88,660	26,000 Added 106.56%	50,400 $88,000
Q4 2022 Feb 14, 2023	SELL	$2.0 - $3.58 $65,200 - $116,708	-32,600 Reduced 57.19%	24,400 $51,000
Q3 2022 Nov 14, 2022	BUY	$2.95 - $4.83 $52,805 - $86,457	17,900 Added 45.78%	57,000 $178,000

127

59.1M

255K

93.6K

Ticker ABSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 92,843,504
Market Cap $249M
Description
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.